CytomX Therapeutics, Inc. (CTMX) vs Shattuck Labs, Inc. (STTK)

A side-by-side comparison of CytomX Therapeutics, Inc. and Shattuck Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CTMX vs STTK

growth of $100 · dividends reinvested · last 6y
CTMX -62.1% (-14.9%/yr)STTK -66.4% (-16.6%/yr)CTMX compounded faster over this window
0100200300Start $100202120222023202420252026$38$34
CTMX STTK

CTMX vs STTK: by the numbers

  • •CTMX is the larger company ($557M vs $534M market cap).
  • •Both run net losses; CTMX's is the smaller (-435.21% vs -5256.80% net margin).
  • •CTMX grew revenue faster over the past five years (2.18% vs -11.25% CAGR).

Metrics side by side

Valuation

MetricCTMXSTTK
P/S ratio30.45534.10
P/B ratio1.852.53

Profitability

MetricCTMXSTTK
Gross margin98.63%-195.10%
Operating margin-29.35%-5150.80%
Net margin-435.21%-5256.80%
ROE-26.37%-24.90%
ROIC-25.42%-26.20%

Growth (annualized)

MetricCTMXSTTK
Revenue CAGR (5Y)2.18%-11.25%
Total return CAGR (5Y)-12.01%-20.11%

Frequently asked

Which has grown faster, CTMX or STTK?
Over the past five years, CTMX grew revenue faster — CTMX at a 2.18% CAGR versus STTK at -11.25%.
How have CTMX and STTK total returns compared?
Over the past 5 years, CTMX delivered -12.01% and STTK delivered -20.11% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.